European Medicines Agency Moves To Amsterdam, FDA Deals Appear Unaffected

November 21, 2017 at 6:56 PM
Amsterdam was chosen Monday (Nov. 20) as the new seat of the European Medicines Agency in the wake of the United Kingdom's earlier vote to exit the European Union. The regulator will be moved to Amsterdam by March 30, 2019, at the latest, and the EMA's dealings with FDA don't appear to be affected. EMA has been upfront in its need to scale down some of its non-essential operations as it relocates, but it appears ongoing efforts to share certain...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.